Cyclo Therapeutics (OTCMKTS:CTDH) Hits New 12-Month High at $6.54

Cyclo Therapeutics, Inc. (OTCMKTS:CTDH)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $6.54 and last traded at $6.30, with a volume of 40771 shares traded. The stock had previously closed at $6.21.

The business’s 50-day simple moving average is $7.83 and its two-hundred day simple moving average is $8.45.

About Cyclo Therapeutics (OTCMKTS:CTDH)

Cyclo Therapeutics, Inc, a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs.

Recommended Story: Trade Deficit

Receive News & Ratings for Cyclo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.